Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study

被引：0
|
作者：
Yao Zhang
Hexiang Yin
Dingding Zhang
Yan Xu
Bin Peng
Liying Cui
机构：
[1] Center of Multiple Sclerosis and Related Disorders,Department of Neurology
[2] Peking Union Medical College Hospital,Medical Research Center
[3] Peking Union Medical College Hospital,Neurosciences Center
[4] Peking Union Medical College & Chinese Academy of Medical Sciences,undefined
[5] Peking Union Medical College Hospital,undefined
[6] Peking Union Medical College & Chinese Academy of Medical Sciences,undefined
[7] Chinese Academy of Medical Sciences,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Multiple sclerosis; Teriflunomide; Real-world; No evidence of disease activity (NEDA); Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4808 / 4816
页数：8
相关论文
共 50 条
  • [41] Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role
    Tan, Hongmei
    Li, Xiang
    Li, Yuxin
    He, Fanru
    Zhangbao, Jingzi
    Zhou, Lei
    Yang, Liqin
    Zhao, Chongbo
    Lu, Chuanzhen
    Dong, Qiang
    Li, Haiqing
    Quan, Chao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [42] A Real-World Experience of Azathioprine Versus First-Line Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis-A Prospective Cohort Study
    Agrawal, Arpit
    Srivastava, M. V. Padma
    Bhatia, Rohit
    Goyal, Vinay
    Singh, Mamta Bhushan
    Vishnu, Venugopalan Y.
    Prabhakar, Anuj
    BRAIN SCIENCES, 2023, 13 (09)
  • [43] Evolution of teriflunomide use in multiple sclerosis: A real-world experience
    Lorefice, L.
    Pilotto, S.
    Fenu, G.
    Cimino, P.
    Firinu, D.
    Frau, J.
    Murgia, F.
    Coghe, G.
    Cocco, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 438
  • [44] Effectiveness of relapsing multiple sclerosis patients switching to teriflunomide following disease progression in a real-world setting
    Miravalle, A.
    Greene, N.
    Miller, R.
    Miller, T.
    Olson, J. M.
    Reddy, S. R.
    Chang, E.
    Fadaee, S.
    McGuey, L.
    Quach, C.
    Lublin, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 705 - 705
  • [45] Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: a real-world multicenter analysis
    Berkovich, R.
    Negroski, D.
    Wynn, D.
    Bzdek, K.
    Lublin, A.
    Quach, C.
    Wells, D.
    Bora, A.
    Ranno, A.
    Dumlao, M.
    Luo, K. Lin
    Rawlings, A.
    Chavin, J.
    Hua, L. H.
    Becker, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 54 - 55
  • [46] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    S. Batista
    C. C. Nunes
    J. J. Cerqueira
    Ana Martins Silva
    J. Correia de Sá
    J. Ferreira
    M. T. Mendonça
    J. Pinheiro
    V. Salgado
    A. S. Correia
    J. Sequeira
    A. Costa
    L. Sousa
    Neurological Sciences, 2021, 42 : 1995 - 2003
  • [47] The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study
    Curti, Erica
    Tsantes, Elena
    Baldi, Eleonora
    Caniatti, Luisa Maria
    Ferraro, Diana
    Sola, Patrizia
    Granella, Franco
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 146 - 152
  • [48] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    Batista, S.
    Nunes, C. C.
    Cerqueira, J. J.
    Martins Silva, Ana
    Correia de Sa, J.
    Ferreira, J.
    Mendonca, M. T.
    Pinheiro, J.
    Salgado, V.
    Correia, A. S.
    Sequeira, J.
    Costa, A.
    Sousa, L.
    NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
  • [49] Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
    Barrero, Francisco
    Mallada-Frechin, Javier
    Luisa Martinez-Gines, Maria
    Eugenia Marzo, Maria
    Meca-Lallana, Virginia
    Izquierdo, Guillermo
    Ramon Ara, Jose
    Oreja-Guevare, Celia
    Meca-Lallana, Jose
    Forero, Lucia
    Sanchez-Veram, Irene
    Jose Moreno, Maria
    PLOS ONE, 2020, 15 (04):
  • [50] Safety and efficacy of dimethyl fumarate in a real-world relapsing-remitting multiple sclerosis population
    Barros, A.
    Sequeira, J.
    Sousa, A.
    Capela, C.
    Pedrosa, R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 877 - 878
12345